Treating tobacco dependence at the intersection of diversity, poverty, and mental illness: A randomized feasibility and replication trial

Nicotine and Tobacco Research

Volumn 17, Issue 8, 2015, Pages 1012-1021

  Hickman, Norval J ^a   Delucchi, Kevin L ^b   Prochaska, Judith J ^c  

^a University of California Office of the President   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE GUM;

ADULT; ALCOHOLISM; ARTICLE; BIPOLAR DEPRESSION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; ETHNIC DIFFERENCE; FEASIBILITY STUDY; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HOUSING; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MINORITY GROUP; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; POVERTY; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT; PSYCHOSIS; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SELF CONCEPT; SMOKING CESSATION; SOCIAL STATUS; THEORETICAL MODEL; TOBACCO DEPENDENCE; UNEMPLOYMENT; URBAN AREA; COMPLICATION; COUNSELING; ETHNIC GROUP; HOSPITAL PATIENT; MEDICALLY UNINSURED; MULTIMODALITY CANCER THERAPY; PROCEDURES; TOBACCO USE DISORDER; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; COUNSELING; ETHNIC GROUPS; FEASIBILITY STUDIES; FEMALE; HUMANS; INPATIENTS; MALE; MEDICALLY UNINSURED; MENTAL DISORDERS; POVERTY; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84939510467     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv034     Document Type: Article

References (63)

1. Center for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged ≥18 years with mental illness-United States, 2009-2011. MMWR Morb Mortal Wkly Rep. 2013;62(5);81-87. www.cdc.gov/mmwr/preview/mmwrhtml/mm6205a2.htm?s_cid=mm6205a2_w. Accessed November 19, 2014.
2. de Leon J, Becona E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002;63(9):812-816. www.psychiatrist.com/privatepdf/2002/v63n09/v63n0911.pdf. Accessed November 19, 2014.
3. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the U.S. population. Tob Control. 2014;23(e2):e147-e153. doi:10.1136/tobaccocontrol-2013-051466.
4. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(11):1107-1115. www.ncbi.nlm.nih.gov/pubmed/15520358. Accessed November 19, 2014.
5. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606-2610. doi:10.1001/jama.284.20.2606.
6. Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31(1):297-314. doi:10.1146/annurev. publhealth.012809.103701.
7. U.S. Department of Labor. FAQs about Affordable Care Act Implementation (Part XIX). 2014. http://www.dol.gov/ebsa/faqs/faq-aca19.html. Accessed November 19, 2014.
8. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42. www.cdc.gov/pcd/issues/2006/apr/05_0180.htm. Accessed November 19, 2014.
9. Steinberg ML, Williams JM, Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control. 2004;13(2):206. http://tobaccocontrol.bmj.com/content/13/2/206.1.long. Accessed November 16, 2014.
10. Fiore M, Jaen C, Baker T, et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public health service report. Am J Prev Med. 2008;35(2):158-176. doi:10.1016/j.amepre.2008.04.009.
11. Joint Commission on Accreditation of Healthcare Organizations. Accreditation Manual for Hospitals. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations; 1992.
12. American Psychiatric Association, Work Group on Substance Use Disorders. Practice Guideline for the Treatment of Patients With Substance Use Disorders. 2nd ed. Washington, DC: American Psychiatric Association; 2006. http://psychiatryonline.org/pb/assets/raw/sitewide/practice:guidelines/guidelines/substanceuse.pdf. Accessed November 19, 2014.
13. Association of American Medical Colleges. Physician Behavior and Practice Patterns Related to Smoking Cessation, Summary Report. Washington, DC: American Association of Medical Colleges; 2007. www.aamc.org/download/55438/data/smokingcessationsummary.pdf. Accessed November 19, 2014.
14. Lawn S, Pols R. Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry. 2005;39(10):866-885. doi:10.1111/j.1440-1614.2005.01697.x.
15. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction. 2009;104(5):719-733. doi:10.1111/j.1360-0443.2009.02545.x.
16. Prochaska JJ, Fletcher L, Hall SE, Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict. 2006;15(1):15-22. doi:10.1080/10550490500419011.
17. Evins AE, Cather C, Deckersbach T, et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol. 2005;25(3):218-225. doi:10.1097/01. jcp.0000162802.54076.18.
18. Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Public Health. 2006;96(10):1808-1814. doi:10.2105/AJPH.2005.080382.
19. McFall M, Atkins DC, Yoshimoto D, et al. Integrating tobacco cessation treatment into mental health care for patients with posttraumatic stress disorder. Am J Addict. 2006;15(5):336-344. doi:10.1080/10550490600859892.
20. Prochaska JJ, Hall SM, Tsoh JY, et al. Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public Health. 2008;98(3):446-448. doi:10.2105/AJPH.2006.101147.
21. Stapleton JA, Watson L, Spirling LI, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction. 2008;103(1):146-154. doi:10.1111/j.1360-0443.2007.02083.x.
22. Prochaska JJ, Hall SE, Delucchi K, Hall SM. Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health. 2014;104(8):1557-1565. doi:10.2105/AJPH.2013.301403.
23. Campion J, Checinski K, Nurse J. Review of smoking cessation treatments for people with mental illness. Adv Psychiatr Treat. 2008;14(3):208-216. doi:10.1192/apt.bp.108.005710.
24. Evins AE, Cather C, Culhane MA, et al. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007;27(4):380-386. doi:10.1097/01. jcp.0b013e3180ca86fa.
25. Schacht L, Ortiz G, Lane GM Jr. Smoking Policies and Practices in State Psychiatric Facilities: Survey Results From 2011. Falls Church, VA: National Association of State Mental Health Program Directors Research Institute, Inc. (NRI); 2012. http://smokingcessationleadership.ucsf.edu/nri_smokingreport2011_final.pdf. Accessed November 19, 2014.
26. Brown R, Ramsey S, Strong D. Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tob Control. 2003;12(suppl 4):IV3-IV10. doi:10.1136/tc.12.suppl_4.iv3, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766133/.
27. Prochaska JJ, Velicer WF, Prochaska JO, Delucchi K, Hall SM. Comparing intervention outcomes in smokers treated for single versus multiple behavioral risks. Health Psychol. 2006;25(3):380-388. doi:0.1037/0278-6133.25.3.380.
28. American Heart Association. Quit Smoking for Good Brochure. Dallas, TX: Krames Patient Education; 2009. www.heart.org/HEARTORG/Conditions/More/ToolsForYourHeartHealth/Quit-Smoking-for-Good_UCM_310564_Article.jsp. Accessed November 19, 2014.
29. Prochaska JJ, Hall SE, Hall SM. Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatr Serv. 2009;60(6):848. doi:10.1176/appi. ps.60.6.848.
30. Kim R, Hickman N, Gali K, Orozco N, Prochaska JJ. Maximizing retention with high risk participants in a clinical trial. Am J Health Promot. 2014;28(4):268-274. doi:10.4278/ajhp.120720-QUAN-355.
31. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2(3):261-270. http://cebp.aacrjournals.org/content/2/3/261. Accessed November 19, 2014.
32. Hickman NJ, Prochaska JJ, Dunn LB. Screening for understanding of research in the inpatient psychiatry setting. J Empir Res Hum Res Ethics. 2011;6(3):65-72. doi:10.1525/jer.2011.6.3.65.
33. Adler NE, Epel ES, Castellazzo G, Ickovics JR. Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women. Health Psychol. 2000;19(6):586-592. doi:10.1037/0278-6133.19.6.586.
34. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x.
35. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res. 2012;14(1):75-78. doi:10.1093/ntr/ntr137.
36. Prochaska J, DiClemente C. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390-395. doi:10.1037//0022-006X.51.3.390.
37. Hall SM, Havassy BE, Wasserman DA. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol. 1990;58(2):175-181. doi:10.1037/0022-006X.58.2.175.
38. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77-84. www.ncbi.nlm.nih.gov/pubmed/8037935. Accessed November 19, 2014.
39. Eisen SV, Normand SL, Belanger AJ, Spiro A III, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care. 2004;42(12):1230-1241. doi:10.1097/00005650-200412000-00010.
40. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. www.ncbi.nlm.nih.gov/pubmed/8628042. Accessed November 19, 2014.
41. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791-804. doi:0.1111/j.1360-0443.1993.tb02093.x.
42. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 2007;32(2):189-198.doi:10.1016/j.jsat.2006.08.002.
43. McLellan AT, Alterman AI, Cacciola J, Metzger D, O'Brien CP. A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis. 1992;180(2):101-110. doi:10.1097/00005053-199202000-00007.
44. Williams DR, Gonzalez HM, Williams S, Mohammed SA, Moomal H, Stein DJ. Perceived discrimination, race and health in South Africa. Soc Sci Med. 2008;67(3):441-452. doi:10.1016/j.socscimed.2008.03.021.
45. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13-25. doi:10.1093/ntr/5.1.13.
46. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77(11):1435-1438. doi:10.2105/AJPH.77.11.1435.
47. Patten CA, Martin JE, Filter KJ, Wolter TD. Utility and accuracy of collateral reports of smoking status among 256 abstinent alcoholic smokers treated for smoking cessation. Addict Behav. 2002;27(5):687-696. doi:10.1016/S0306-4603(01)00202-7.
48. Barnett PG, Wong W, Hall S. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression. Addiction. 2008;103(5):834-840. doi:10.1111/j.1360-0443.2008.02167.x.
49. SAS Institute, Inc. SAS/STAT 9.2 User's Guide. Cary, NC: SAS Institute, Inc; 2008.
50. Prochaska JO, Velicer WF, Fava JL, et al. Counselor and stimulus control enhancements of a stage-matched expert system intervention for smokers in a managed care setting. Prev Med. 2001;32(1):23-32. www.ncbi.nlm.nih.gov/pubmed/11162323.Accessed November 17, 2014.
51. Prochaska JO, Velicer WF, Fava JL, Rossi JS, Tsoh JY. Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation. Addict Behav. 2001;26(4):583-602. www.ncbi.nlm.nih.gov/pubmed/11456079. Accessed November 17, 2014.
52. Prochaska JO, Wright JA, Velicer WF. Evaluating theories of health behavior change: a hierarchy of criteria applied to the transtheoretical model. Appl Psychol. 2008;57(4):561-588. doi:10.1111/j.1464-0597.2008.00345.x.
53. Lenth RV. Some practical guidelines for effective sample size determination. Am Stat. 2001;55(3):187-193. http://conium.org/~maccoun/PP279_Lenth.pdf. Accessed November 17, 2014.
54. Reitzel LR, Kendzor DE, Cao Y, Businelle MS. Subjective social status predicts quit-day abstinence among homeless smokers. Am J Health Promot. 2014;29(1):43-45. doi:10.4278/ajhp.130228-ARB-88.
55. Reitzel LR, Nguyen N, Cao Y, et al. Race/ethnicity moderates the effect of prepartum menthol cigarette use on postpartum smoking abstinence. Nicotine Tob Res. 2011;13(12):1305-1310. doi:10.1093/ntr/ntr095.
56. Chen D, Yang TC. The pathways from perceived discrimination to selfrated health: an investigation of the roles of distrust, social capital, and health behaviors. Soc Sci Med. 2014;104:64-73. doi:10.1016/j. socscimed.2013.12.021.
57. Kendzor DE, Businelle MS, Reitzel LR, et al. Everyday discrimination is associated with nicotine dependence among African American, Latino, and White smokers. Nicotine Tob Res. 2014;16(6):633-640. doi:10.1093/ntr/ntt198.
58. Williams DR, Neighbors HW, Jackson JS. Racial/ethnic discrimination and health: findings from community studies. Am J Public Health. 2008;98(suppl 1):S29-37. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518588/. Accessed November 19, 2014.
59. Kendzor DE, Businelle MS, Reitzel LR, et al. The influence of discrimination on smoking cessation among Latinos. Drug Alcohol Depend. 2014;136:143-148. doi:10.1016/j.drugalcdep.2014.01.003.
60. Shumway M, Alvidrez J, Leary M, et al. Impact of capacity reductions in acute public-sector inpatient psychiatric services. Psychiatr Serv. 2012;63(2):135-141. doi:10.1176/appi.ps.201000145.
61. Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res. 2013;15(5):978-982. doi:10.1093/ntr/nts205.
62. Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ. Cost effectiveness of smoking cessation treatment initiated during psychiatric hospitalization. J Clin Psychiatry. In Press.
63. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20(6):64-78.